12:00 AM
 | 
May 18, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Telintra: Phase II started

Last month, Telik began a Phase II trial to evaluate oral Telintra given daily in 20...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >